Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Nutex Health (NUTX) Interest & Investment Income (2020 - 2022)

Nutex Health (NUTX) has disclosed Interest & Investment Income for 6 consecutive years, with $368.0 as the latest value for Q1 2022.

  • For Q1 2022, Interest & Investment Income rose 222.81% year-over-year to $368.0; the TTM value through Mar 2022 reached $1171.0, up 2.36%, while the annual FY2021 figure was $917.0, 10.97% down from the prior year.
  • Interest & Investment Income hit $368.0 in Q1 2022 for Nutex Health, up from $288.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $1030.0 in Q4 2020 and bottomed at $114.0 in Q1 2021.
  • Average Interest & Investment Income over 3 years is $385.83, with a median of $279.0 recorded in 2021.
  • Year-over-year, Interest & Investment Income tumbled 72.04% in 2021 and then skyrocketed 222.81% in 2022.
  • Nutex Health's Interest & Investment Income stood at $1030.0 in 2020, then crashed by 72.04% to $288.0 in 2021, then grew by 27.78% to $368.0 in 2022.
  • According to Business Quant data, Interest & Investment Income over the past three periods came in at $368.0, $288.0, and $270.0 for Q1 2022, Q4 2021, and Q3 2021 respectively.